We can't find the internet
Attempting to reconnect
15807.1;9 PFLS-LS
Development of transducible artificial transcription factor therapeutics (TAFTs): A new generation of drugs for ophthalmic disorders.
Zusammenfassung
Development of transducible artificial transcription factor therapeutics (TAFTs): A new generation of drugs for ophthalmic disorders.
Weitere Texte
Abstract
The proposed CTI project aims to develop TAFTs for the treatment of ophthalmic diseases such as retinal vascular diseases, glaucoma and age-related macula degeneration. TAFTs are a new class of biologics modulating gene expression. They are designed to target expression of specific receptor proteins connected to the pathophysiology of eye diseases. The project is expected to bring TAFTs from the preclinical to the clinical stage, thus strenghening Aliophtha's TAFT pipeline.
Beteiligte
Albert Neutzner
Kontaktperson
albert.neutzner@unibas.ch
University of Basel Albert Neutzner Hebelstrasse 20 4031 Basel BS CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2013-09-30
- Enddatum
- 2015-06-30
- Bewilligte Gesamtkosten
- CHF 819287.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Nicht aufteilbare / nicht zuteilbare Forschung
Forschungsdisziplinen
- T490 Biotechnology 100.0%